Home/Filings/4/0001437749-23-002374
4//SEC Filing

McIntyre Gail Frances 4

Accession 0001437749-23-002374

CIK 0001513818other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:25 PM ET

Size

5.4 KB

Accession

0001437749-23-002374

Insider Transaction Report

Form 4
Period: 2023-02-01
McIntyre Gail Frances
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-01+700,000700,000 total
    Exercise: $1.67Exp: 2033-01-31Common Stock (700,000 underlying)
Footnotes (1)
  • [F1]These options vest over three years with 50% vesting on the one-year anniversary of the date of grant and the remaining 50% vesting on a pro rata basis on a monthly basis over a two-year period commencing on the month following the one-year anniversary of the grant date.

Issuer

Aravive, Inc.

CIK 0001513818

Entity typeother

Related Parties

1
  • filerCIK 0001492646

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:25 PM ET
Size
5.4 KB